NCT07083583 (IRON-BD) is a clinical trial of IV Iron (standard of care) in Bleeding Disorders, sponsored by Nicoletta C Machin.

Who is sponsoring NCT07083583?

NCT07083583 is sponsored by Nicoletta C Machin.

What drugs are being tested in NCT07083583?

Interventions in NCT07083583: IV Iron (standard of care).

What condition does NCT07083583 study?

NCT07083583 studies Bleeding Disorders, Iron, Platelet, Bleeding.

Is NCT07083583 still recruiting?

NCT07083583 is currently recruiting now. Last updated 3 October 2025.

Last reviewed 2025-10-03 · How we verify

NCT07083583: IRON-BD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

Recruiting now Last updated 3 October 2025

What this trial tests

trial testing IV Iron (standard of care) in Bleeding Disorders in 40 participants. Currently enrolling.

Timeline

8 August 2025

Primary endpoint
1 October 2027

1 October 2027

Quick facts

Lead sponsor	Nicoletta C Machin
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	40
Start date	8 August 2025
Primary completion	1 October 2027
Estimated completion	1 October 2027
Sites	1 location across United States

Drugs / interventions tested

IV Iron (standard of care) — full drug profile →

Conditions studied

Bleeding Disorders — all drugs for Bleeding Disorders →
Iron — all drugs for Iron →
Platelet — all drugs for Platelet →
Bleeding — all drugs for Bleeding →

Sponsor

Nicoletta C Machin — full company profile →

Who can join

15 and older, any sex, with Bleeding Disorders or Iron. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, single-arm, single-center observational study evaluating the impact of intravenous (IV) iron replacement in patients with inherited bleeding disorders and iron deficiency (ferritin \<50ng/dL). Subjects will undergo baseline bleeding assessments, quality-of-life measures, and laboratory tests before receiving standard-of-care IV iron. Follow-up blood work and questionnaires will be conducted post-replacement to assess for changes

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bleeding Disorders

Currently open trials in the same condition.

NCT07205523 — High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) · recruiting

Other Nicoletta C Machin trials

Trials by the same sponsor.

NCT04344860 — Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07083583 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nicoletta C Machin
Last refreshed: 3 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07083583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing